Login/Sign Up
₹2024.6*
MRP ₹2249.5
10% off
₹1912*
MRP ₹2249.5
15% CB
₹337.5 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Country of origin
Alcohol
Caution
Limit alcohol intake, along with Eltropag Tablet 7's, to attain the maximum efficacy of Eltropag Tablet 7's and rule out any possibility of worsening of side effects.
Pregnancy
Unsafe
Eltropag Tablet 7's is not recommended in pregnancy. It may affect and harm the developing baby. Please consult your doctor if you are pregnant or planning to conceive.
Breast Feeding
Caution
It is not known if Eltropag Tablet 7's is excreted into the breast milk. Please consult your doctor for more information before taking Eltropag Tablet 7's if you are a nursing mother.
Driving
Caution
Eltropag Tablet 7's may cause dizziness and tiredness affecting your ability to concentrate and drive. Hence, it is recommended not to drive or operate machinery until you are mentally alert.
Liver
Caution
Let your doctor know if you have any history of liver diseases before taking Eltropag Tablet 7's. Eltropag Tablet 7's may cause an increase in liver enzymes. Your doctor may start the treatment with a lower dose of Eltropag Tablet 7's.
Kidney
Caution
Eltropag Tablet 7's should be used with caution in cases of renal impairment. It is advised to seek doctor advice before starting Eltropag Tablet 7's if you have any kidney problems.
Children
Caution
Eltropag Tablet 7's is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.
Product Substitutes
About Eltropag Tablet 7's
Eltropag Tablet 7's belongs to the class of 'platelet-stimulating agents' primarily used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. Eltropag Tablet 7's is also used to treat severe aplastic anaemia (SAA) in adults. Idiopathic thrombocytopenic purpura is an immune condition associated with low levels of platelets. Hepatitis C is an infection and inflammation of the liver caused due to hepatitis C virus. Severe aplastic anaemia is a condition in which the bone marrow doesn't make enough blood cells.
Eltropag Tablet 7's contains 'Eltrombopag' which belongs to the class of 'thrombopoietin receptor agonists'. Thrombopoietin is a glycoprotein hormone that stimulates the formation of megakaryocytes (large bone marrow cells) and further regulates platelet's production. Eltropag Tablet 7's works by increasing these large bone marrow cells responsible for the production of platelets. Thus, Eltropag Tablet 7's helps increase these bone marrow cells, thereby stimulating the number of platelets, which further lowers the risk of bleeding.
Take Eltropag Tablet 7's as prescribed by your doctor. In some cases, Eltropag Tablet 7's can cause common side effects like nausea, diarrhoea, headache, muscle pain, tiredness, loss of appetite, fever, anaemia (lack of blood cells), cough and tingling numbness. These side effects are not familiar to everyone who take Eltropag Tablet 7's and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Let your doctor know if you have any allergic reactions to Eltropag Tablet 7's or any other medicines, before starting Eltropag Tablet 7's. It is essential to inform your doctor if you have any heart, kidney or liver problems, blood disorders, blood clotting problems and cataracts before starting Eltropag Tablet 7's. It is advised to consult the doctor if you are pregnant or planning to conceive. Eltropag Tablet 7's is not indicated for use in breastfeeding since it passes into the breast milk. Eltropag Tablet 7's may make you dizzy, hence drive or operate machinery only when you are mentally alert.
Uses of Eltropag Tablet 7's
Medicinal Benefits
Eltropag Tablet 7's contains 'Eltrombopag,' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections and severe aplastic anaemia (SAA) in adults. Eltropag Tablet 7's works by increasing megakaryocytes, the large bone marrow cells responsible for the production of platelets. The increase in these bone marrow cells stimulates the production of platelets. Thus Eltropag Tablet 7's prevents bleeding episodes by increasing the number of platelets in the blood.
Directions for Use
Side Effects of Eltropag Tablet 7's
Drug Warnings
If you are known to be allergic to Eltropag Tablet 7's or other medicines, please inform your doctor in advance. Brief your medical history if you have blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, liver or kidney diseases before starting Eltropag Tablet 7's. Take Eltropag Tablet 7's at least two hours before or four hours after consuming antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminium, selenium and zinc), dairy products, calcium-enriched foods and fortified juices since they interfere with the absorption of Eltropag Tablet 7's. Eltropag Tablet 7's is not recommended during pregnancy since it may have harmful effects on the foetus. Consult your doctor before using Eltropag Tablet 7's if you are a breastfeeding mother. Do not drive or operate machinery since Eltropag Tablet 7's may cause side effects like dizziness and tiredness, affecting your ability to concentrate and drive. Avoid or limit alcohol consumption with Eltropag Tablet 7's as it may affect the efficacy of Eltropag Tablet 7's. Eltropag Tablet 7's is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.
Drug-Drug Interactions
Drug-Food Interactions
Drug-Diseases Interactions
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
Diet & Lifestyle Advise